Prostate Health

Newer drugs are improving survival for men with metastatic prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Men with prostate cancer that has spread outside the gland now have several newer drug options available for treatment, and research has found that taking any of them is likely to improve survival duration.

We heard you — incontinence affects men too. Here’s what you need to know

Matthew Solan

Executive Editor, Harvard Men's Health Watch

Urinary incontinence is more common in women, but men experience it too, particularly as they get older. Whether it’s urge incontinence or stress incontinence, there are strategies and treatments that can help.

Study investigates treatment regret among prostate cancer survivors

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Surveys of over 900 men who were diagnosed with prostate cancer in the 1990s found that approximately 15% had some regret over their treatment choices. Study authors encourage doctors and patients to have frank and thorough discussions about about the risks and benefits of various forms of treatment for prostate cancer.

Time to rethink the debate on PSA testing

The debate about PSA screening for prostate cancer has been going on for decades, and research has been similarly divided. For most men, the best advice is to talk with your doctor so the benefits and risks of the test are clear.

Strong study shows no link between vasectomy and prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

In contrast to earlier research, a review of dozens of studies involving millions of men who had vasectomies found no proof that having a vasectomy increases a man’s risk of prostate cancer.

Combination hormonal therapy boosts survival in men with aggressive prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

The results of two studies found that using the drug abiraterone in combination with other hormonal therapy drugs to treat aggressive prostate cancer produced more favorable results than the first-line therapy alone.

Yoga improves treatment-related symptoms in men with prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

Men who participated in yoga classes twice a week while being treated for prostate cancer reported less fatigue and better urinary and erectile function, compared to other men in the study who did not do yoga.

Combining surgery, radiation, and hormonal therapy dramatically extends survival in men with advanced prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

A small pilot study that combined surgery, radiation, and hormone therapy may lead to future treatment options for men with prostate cancer that has spread beyond the gland.

Adding hormonal therapy to radiation lengthens survival in men with recurring prostate cancer

Charlie Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

For men who have had prostate gland removal surgery, results from a new study show that a combination of radiation treatment and androgen deprivation therapy is more effective for treating PSA recurrence than radiation alone.

To PSA test or not to PSA test: That is the discussion

The recommended guidelines for whether men should have the prostate cancer screening test have changed in recent years. A man considering the test should talk with his doctor and understand all the pros and cons involved.